Yahoo Finance • 25 days ago
Investing.com -- Mizuho has refreshed its monthly Americas Top Picks list, adding new high-conviction ideas selected by its U.S. equity analysts. The list highlights “our analysts’ highest conviction, catalyst-driven ideas,” Mizuho says,... Full story
Yahoo Finance • 28 days ago
As the United States market enters December with a downturn in major indices like the Dow Jones, S&P 500, and Nasdaq due to risk-off sentiment impacting big tech and crypto-tied shares, investors are closely monitoring high growth opportun... Full story
Yahoo Finance • last month
In trading on Monday, shares of ADMA Biologics Inc (Symbol: ADMA) crossed above their 200 day moving average of $17.84, changing hands as high as $18.44 per share. ADMA Biologics Inc shares are currently trading up about 7.1% on the day.... Full story
Yahoo Finance • last month
Summers Value Partners, an investment management company, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The Summers Value Fund LP returned a net return of 20.4% net in Q3 2025, surpassing the... Full story
Yahoo Finance • last month
The United States market has recently experienced mixed performances, with the Dow Jones Industrial Average declining for two consecutive days while technology shares have shown signs of rebounding. Amidst these fluctuations, investors are... Full story
Yahoo Finance • 2 months ago
As the U.S. market grapples with a mix of earnings reports and renewed U.S.-China trade tensions, major stock indexes have been under pressure, with the tech-heavy Nasdaq and other indices closing lower. In this environment, identifying hi... Full story
Yahoo Finance • 3 months ago
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in General Dynamics Corp (Symbol: GD), where a total volume of 10,561 contracts has been traded thus far today, a contract v... Full story
Yahoo Finance • 3 months ago
Renaissance Investment Management, an investment management company, released its Q2 2025 “Small Cap Growth Strategy” investor letter. A copy of the letter can be downloaded here. The stock market was highly volatile in the second quarter.... Full story
Yahoo Finance • 3 months ago
As the United States stock market continues to reach new heights, with major indices like the S&P 500 and Nasdaq Composite posting consecutive weeks of gains, investors are paying close attention to high-growth sectors such as technology.... Full story
Yahoo Finance • 4 months ago
The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals a... Full story
Yahoo Finance • 4 months ago
Dublin, Sept. 05, 2025 (GLOBE NEWSWIRE) -- The "Immunoglobulin Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025 To 2033" report has been added to R... Full story
Yahoo Finance • 4 months ago
As the U.S. market experiences slight gains, with the Dow Jones and S&P 500 inching higher amid anticipation for Nvidia's earnings report, investors are closely monitoring developments that could impact broader market sentiment. In such a... Full story
Yahoo Finance • 4 months ago
We came across a bullish thesis on ADMA Biologics, Inc. on Archive Invest’s Substack by Felix. In this article, we will summarize the bulls’ thesis on ADMA. ADMA Biologics, Inc.'s share was trading at $17.80 as of August 22nd. ADMA’s trail... Full story
Yahoo Finance • 4 months ago
President and CEO of ADMA Biologics NASDAQ:ADMA, Adam S. Grossman, sold 21,000 shares of common stock on August 15, 2025, for approximately $354,480. The shares were sold at a price of $16.88. The transaction comes as ADMA maintains strong... Full story
Yahoo Finance • 4 months ago
As the U.S. market experiences a mix of record highs and tempered expectations due to recent inflation reports, investors are closely monitoring economic indicators that could influence Federal Reserve policy decisions on interest rates. I... Full story
Yahoo Finance • 5 months ago
Investing.com - ADMA Biologics Inc (NASDAQ: ADMA) reported second quarter EPS of $0.1473, worse than the analyst estimate of $0.1533. Revenue for the quarter came in at $121.98M versus the consensus estimate of $124.13M. ADMA Biologics... Full story
Yahoo Finance • 5 months ago
2Q 2025 Total Revenue of $122.0 Million, a 14% YoY Increase, and a 29% YoY Increase Excluding a Prior Year Non-Recurring Item 2Q 2025 GAAP Net Income of $34.2 Million, a 7% YoY Increase 2Q 2025 Adjusted EBITDA(1) of $50.8 Million, a 59%... Full story
Yahoo Finance • 5 months ago
Major earnings expected after the bell on Wednesday include: * Realty Income Corporation (O [https://seekingalpha.com/symbol/O]) * Energy Transfer LP (ET [https://seekingalpha.com/symbol/ET]) * Occidental Petroleum Corporation (OXY... Full story
Yahoo Finance • 5 months ago
September S&P 500 E-Mini futures (ESU25 [https://www.barchart.com/futures/quotes/ESU25]) are trending up +0.24% this morning as investors digested U.S. President Donald Trump’s latest tariff threats and weak economic data, while shifting t... Full story
Yahoo Finance • 5 months ago
RAMSEY, N.J. and BOCA RATON, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and... Full story